Beacon Consulting Group

Case Studies

Biotech Company - Infectious Disease Market Assessment

Business Case

A development-stage biotech company with a highly specialized technological platform was developing a therapy for an infectious disease. Their lead compound was in Phase II, with a planned launch just a few years away. The company needed to better understand the market to help drive the appropriate decisions concerning future clinical studies and the claims needed at launch. They were also in discussions with several potential partners and needed a thorough understanding of what value to place on the asset in these discussions.

Device Company Launch Plan

Business Case

A small device company was planning a US launch within the next two years. However, they had limited understanding of the market dynamics, or where and when their product would be used post-launch. They asked Beacon Consulting Group to assess the market and guide them in their launch planning activities.

Cardiovascular Launch Plan

Business Case

A small cardiovascular company was developing a naturally occurring metabolite of a common vitamin to prevent mortality after coronary artery bypass graft (CABG) surgery. With an ongoing Phase III study, the company was just over one year from launch without firm plans to get to market, understanding of how to prepare the market for their novel therapy, or understanding of how a “naturally occurring product” would be reimbursed.

Suboptimal Launch Success

Business Case

A specialty pharmaceutical company found sales were significantly below expectations within six months of launch. The marketing team had changed strategies a number of times in less than one year, there was significant turnover in the sales team, and the sales leadership and marketing leadership were not in agreement on best path forward.